Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Cachexia × Ibuprofen × Clear all

Phase

Status

Unknown 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 3 Pain 2 Lymphoma, Follicular 2 Breast Neoplasms 2 Trigger Finger Disorder 1 Prostatic Neoplasms 1 Pituitary Neoplasms 1 Patient Satisfaction 1 Nose Neoplasms 1 Mucositis 1 Menorrhagia 1 Leiomyoma 1 Hemorrhage 1 Head and Neck Neoplasms 1 Ganglion Cysts 1 Esthesioneuroblastoma, Olfactory 1 Dupuytren Contracture 1 De Quervain Disease 1 Cognitive Dysfunction 1 Carpal Tunnel Syndrome 1 Cachexia 1 Adenomyosis 1 Abnormalities, Radiation-Induced 1

Interventions

Megestrol Acetate 4 Standard of Care 2 Physical Therapy Modalities 2 Nutrition Assessment 2 Infliximab 2 Exercise 2 Blood Specimen Collection 2 testosterone enanthate 1 remune 1 ostarine 1 olanzapine-fluoxetine combination 1 irinotecan sucrosofate 1 clazakizumab 1 bermekimab 1 anamorelin 1 Sodium Chloride 1 Radiotherapy 1 Powders 1 Pentoxifylline 1 Olanzapine 1 Mirtazapine 1 Melatonin 1 Megestrol 1 Ibuprofen 1 High-Energy Shock Waves 1 Ghrelin 1 Gemcitabine 1 Fluoxetine 1 Fluorouracil 1 Flour 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02330926 2025-08-29

MENAC

Norwegian University of Science and Technology

Phase 3 Completed

Cachexia, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡